GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹269 Cr | ₹320 Cr | ₹3.82 Cr | ₹3.93 Cr | ₹4.07 Cr |
What is the latest Total Debt ratio of GLAND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹320 Cr |
| Mar2023 | ₹3.82 Cr |
| Mar2022 | ₹3.93 Cr |
| Mar2021 | ₹4.07 Cr |
How is Total Debt of GLAND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | -15.81 | |
| Mar2024 | ₹320 Cr | 8,269.07 | |
| Mar2023 | ₹3.82 Cr | -2.85 | |
| Mar2022 | ₹3.93 Cr | -3.34 | |
| Mar2021 | ₹4.07 Cr | - | |
Compare Total Debt of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹41,978.5 Cr | 7% | 2.4% | 23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 7% |
2.4% |
23.8% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses